Hansa Biopharma AB (HNSA.ST) Q3 2024 Earnings

Jul 18Confirmed
Q3 2023
Q4 2023
Q1 2024
Q3 2024
-3.6
-3.32
-3.04
-2.76

Details

Expected EPS
-2.764588253233347
Actual EPS
-3.2812723053
Surprise EPS
-0.52
Surprise Percent
-18.69%

Description

⁨Hansa Biopharma AB⁩ (⁦HNSA.ST⁩) has reported earnings of ⁦-3.2812723053⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts